You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
The company will rely more on distribution partners in Europe for its Unyvero product line while continuing highly targeted commercialization efforts in the US.
The company is developing a new gold standard comparator test after it encountered problems with typical culture methods it used in developing a new pneumonia assay.
The BioFire FilmArray Pneumonia Panel was cleared by the FDA while the BioFire FilmArray Pneumonia Panel Plus was CE marked.
The drug-device combination measures activity of live organisms by detecting metabolites, and can be used to indicate virulence and guide treatment.
The three-year extension increases the minimum purchase commitments for the Unyvero system, resulting in an increase in potential revenues of €30 million to Curetis.
The Envisia test uses RNA sequencing and machine learning to diagnose idiopathic pulmonary fibrosis.
Sales were driven by a strong flu season and growth in Asia-Pacific business.
The firm also received approval from the Singapore Health Sciences Authority to market the Unyvero blood culture cartridges.
The company reported that it signed agreements for 337 instruments , while revenue-generating placements totaled 78 across the US, European, and Middle East regions.
The PCR-based cartridge is designed to detect 21 pneumonia pathogens and 19 genetic markers of antibiotic resistance, and runs on the company's Unyvero system.